Objective. To determine prevalence,patterns, and correlates of voluntary fl
unitrazepam use in a sample of sexually active adolescent and young adult w
omen 14 to 26 years of age.
Design. Cross-sectional survey.
Setting. University-based ambulatory reproductive health clinics.
Patients or Other Participants. There were 904 women self-identified as whi
te, African-American, or Mexican-American.
Interventions. None.
Main Outcome Measure. Lifetime, frequency, patterns, and physical effects o
f flunitrazepam use.
Results. Lifetime use was reported by 5.9% (n = 53) of subjects, with frequ
ency of use ranging from I to 40 times. Flunitrazepam was taken most often
with alcohol (74%), and 49% took this substance with other illicit drugs. L
ogistic regression analyses controlling for age and race/ethnicity found th
at users were significantly more likely than were nonusers to report lifeti
me use of marijuana (odds ratio [OR] = 3.6) or LSD (OR = 5.2), having a pee
r or partner who used flunitrazepam (OR = 21.7), pressure to use flunitraze
pam when out with friends (OR = 2.7), and a mother who had at least a high
school education (OR = 2.6). Finally, 10% of voluntary users reported exper
iencing subsequent physical or sexual victimization.
Conclusions. Voluntary use of flunitrazepam is becoming a health concern to
sexually active young women who reside in the southwestern United States.
Young women who have used LSD or marijuana in the past or who have a peer o
r partner who used this drug appear to be at the greatest risk.